| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.08 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.34 | 0.08 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |